SCHEMBL20182291

SCHEMBL20182291

CCC(/C(=C/Nc1ccc(F)cc1F)N=N)n1cc(-c2cnc(C(F)F)nc2)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.38
NTRK3 Q16288 1/20 0.38
NTRK2 Q16620 1/20 0.38
NEK7 Q8TDX7 5/20 0.37
EIF2AK3 Q9NZJ5 3/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
PRKDC P78527 1/20 0.35
FLT3 P36888 5/20 0.35
SRC P12931 2/20 0.34
KDR P35968 2/20 0.34
TEK Q02763 2/20 0.34
MET P08581 1/20 0.33
AXL P30530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182255 0.92 SRC (0.39) NEK7EIF2AK3PIK3CDPIK3CAPIK3CB
SCHEMBL20182294 0.90 CFTR (0.40) NTRK1NTRK3NTRK2NEK7EIF2AK3
SCHEMBL20182292 0.89 NEK7 (0.37) NTRK1NTRK3NTRK2NEK7EIF2AK3
SCHEMBL20182289 0.85 NTRK1 (0.36) NTRK1NTRK3NTRK2NEK7EIF2AK3
SCHEMBL20182265 0.85 NTRK1 (0.36) NTRK1NTRK3NTRK2NEK7EIF2AK3
SCHEMBL20181910 0.84 CFTR (0.38) NTRK1NTRK3NTRK2NEK7EIF2AK3
SCHEMBL20182197 0.82 CFTR (0.43) EIF2AK3PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182204 0.81 KDR (0.37) NEK7EIF2AK3PIK3CDPIK3CAPIK3CB
SCHEMBL20181912 0.81 SRC (0.41) EIF2AK3PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20181883 0.80 NTRK1 (0.40) NTRK1NTRK3NTRK2NEK7EIF2AK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed